Results
1
-
10
of
48
<
1
2
3
4
5
>
Fava M; Okame T; Matsushima Y; Perry P; Weiller E; Baker RA.
Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
,
The international journal of neuropsychopharmacology
[PubMed: 27784751]
[DOI: 10.1093/ijnp/pyw087]
Brexpiprazole (Rexulti) for schizophrenia and depression.
,
The Medical letter on drugs and therapeutics
Markovic M; Gallipani A; Patel KH; Maroney M.
Brexpiprazole.
,
The Annals of pharmacotherapy
[DOI: 10.1177/1060028016678262]
Aftab A; Gao K.
The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder.
,
Expert opinion on drug discovery
[DOI: 10.1080/17460441.2017.1354849]
Milienne-Petiot M; Geyer MA; Arnt J; Young JW.
Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.
,
Psychopharmacology
[DOI: 10.1007/s00213-017-4543-7]
Mombereau C; Arnt J; M?rk A.
Involvement of presynaptic 5-HT<sub>1A</sub> receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats.
,
Pharmacology, biochemistry, and behavior
[DOI: 10.1016/j.pbb.2016.12.015]
Hsu WY; Lane HY; Lin CH.
Brexpiprazole for the treatment of schizophrenia.
,
Expert opinion on pharmacotherapy
[DOI: 10.1080/14656566.2016.1274972]
Sussman M; Yu J; Kamat SA; Hartry A; Legacy S; Duffy R; Aigbogun MS.
Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
,
Journal of affective disorders
[DOI: 10.1016/j.jad.2016.09.006]
Beyer JL; Weisler RH.
Adjunctive brexpiprazole for the treatment of major depressive disorder.
,
Expert opinion on pharmacotherapy
[DOI: 10.1080/14656566.2016.1254188]
Malla A; Ota A; Nagamizu K; Perry P; Weiller E; Baker RA.
The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study.
,
International clinical psychopharmacology
[DOI: 10.1097/YIC.0000000000000140]
<
1
2
3
4
5
>